VISTN — Vistin Pharma ASA Cashflow Statement
0.000.00%
Last trade - 00:00- NOK1.09bn
- NOK1.07bn
- NOK429.09m
- 91
- 55
- 71
- 88
Annual cashflow statement for Vistin Pharma ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | — | — | — | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -124 | 32 | -6.01 | 58.5 | 80.5 |
| Depreciation | |||||
| Non-Cash Items | 0 | — | — | — | — |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -31.1 | -28.9 | -16.8 | 14.7 | 8.37 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -146 | 13.7 | -10.5 | 90.6 | 108 |
| Capital Expenditures | -53.1 | -31.9 | -64.3 | -17.9 | -40.8 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 1.73 | 0.265 | 0.028 | 0.22 | 0.508 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -51.4 | -31.7 | -64.3 | -17.7 | -40.3 |
| Financing Cash Flow Items | -0.753 | -0.289 | -2.09 | -2.1 | -2.19 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -45.5 | -23.3 | 40.5 | -48.1 | -81 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -243 | -41.3 | -34.3 | 24.8 | -13.4 |